Global Varicose Veins Treatment Devices Market to Witness Huge Growth by 2025

MAY 06, 2019: The global varicose veins treatment devices market is expected to reach USD 1.7 billion by 2025, according to a new report by Radiant Insights, Inc. It is anticipated to register a CAGR of 6.3% during the forecast period. Rising investments by the key healthcare companies to develop innovative and effective products is likely to drive the growth.

To Request A Sample Copy Of This Report @:   https://www.radiantinsights.com/research/varicose-veins-treatment-devices-market/request-sample

Varicose veins can be unsightly and can lead to considerable discomfort in some cases. Available treatments for varicose veins have improved since the last few years. Various healthcare providers are offering minimally invasive techniques such as radiofrequency ablation and laser therapies. Due to the risk of infections associated with invasive surgeries, surgical vein stripping methods have been replaced by noninvasive procedures. Sclerotherapy is the most popular procedure and is used as a first-line of treatment among endovenous ablation and surgical stripping.

To Browse Full Research Report @:
https://www.radiantinsights.com/research/varicose-veins-treatment-devices-market

North America held the leading market share in terms of revenue in 2018 due to technological advancements and the fact that about 30 million Americans suffer from varicose vein each year. In U.S., Medicare provides coverage to the patients undergoing sclerotherapy treatment for varicose veins, which can increase its adoption by the care providers and especially by the patients.

Some market players purchase products from core manufacturers and distribute. For instance, AngioDynamics, Inc. purchased Asclera from Merz in March 2016. AngioDynamics announced that it has entered into an agreement with Merz North America, a part of the global Merz Pharma Group, for the distribution of Asclera injection within U.S. In another development, Medtronic announced that the new CPT codes may aid in getting positive coverage for its VenaSeal closure device from the public and private insurers in U.S. in November 2017.

Development of innovative products, commercialization, and availability of reimbursements are some of the strategies undertaken by the market players to strengthen their position in the varicose veins treatment devices market. In May 2016, Navarro opened a vein center in U.S. with a vision to educate the community about chronic venous insufficiency and varicose veins and the proper treatment options.

Further key findings from the report suggest:

• Sclerotherapy segment led the market in 2018 due to the advantages of this treatment such as no scarring; no need for anesthesia; no need for hospital admission; simple follow-up treatments; and favorable reimbursement policies

• Endovenous ablation segment is anticipated to witness the fastest growth over the forecast period as this treatment is preferred over the conventional procedures such as surgical stripping and ligation

• Asia Pacific is expected to be the fastest growing region in the forthcoming years due to rising awareness about minimally invasive and noninvasive procedures, rising disposable income levels, and a large base of geriatric population

• Some of the key players operating in the varicose veins treatment devices market are AngioDynamics, Inc.; Medtronic plc; Syneron Medical Ltd.; Biolitec AG; Lumenis Ltd.; Energist Group; Eufoton srl; and Teleflex, Inc.

• In addition, market players acquire other vascular businesses to boost their own product portfolio and overall revenue. For instance, Teleflex acquired Vascular Solutions, Inc. in 2017.

Table of Contents

Chapter 1 Research Methodology

1.1 Market Segmentation & Scope

1.2 Research Methodology

1.3 Information Procurement

1.3.1 Purchased Database

1.3.2 GVR’s Internal Database

1.3.3 Secondary Sources

1.3.4 Primary Research

1.4 Information Analysis

1.4.1 Data analysis models

1.5 Market Formulation & Data Visualization

1.6 Model Details

Chapter 2 Executive Summary

2.1 Market Outlook

2.2 Segment Outlook

2.3 Competitive Insights

Chapter 3 Market Variables, Trends & Scope

3.1 Market Segmentation

3.1.1 Market Driver Analysis

3.1.1.1 Growing preference for minimally invasive treatment procedures

3.1.1.2 Introduction of technologically advanced devices

3.1.1.3 Increasing geriatric population

3.1.2 Market Restraint Analysis

3.1.2.1 High procedural costs and inconsistent reimbursement structure

3.1.2.2 Risk factors associated with varicose veins treatment

3.2 Penetration & Growth Prospects Mapping

3.3 Varicose Vein Treatment Devices Market – PESTLE Analysis

3.4 Industry Analysis – Porter’s Five Forces Analysis

3.5 Varicose Vein Treatment Market, by Therapy Type

3.6 Patient Population

3.6.1 Female vs. Male Population

3.6.2 Geriatric vs. Adult Population

3.7 Reimbursement Scenario

3.8 Spider Veins: Treatment Scenario

3.9 Varicose Vein Treatment: Future Trends

3.9.1 VenaSeal Closure System

3.9.2 Varithena

To See More Reports of This Category by Radiant Insights:
https://www.radiantinsights.com/catalog/medical-devices

About Radiant Insights:Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. It assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. The Organization has a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions. 

Media Contact:Company Name: Radiant Insights, Inc
Contact Person: Michelle Thoras
Email: sales@radiantinsights.com
Phone: (415) 349-0054
Address: 201 Spear St #1100, Suite #3036
City: San Francisco
State: California
Country: United States
For more information, Visit: http://www.radiantinsights.com